Table 6. Early outcomes (within 30 days postoperatively).
| Parameter | Events/total | N | Weighted pooled estimate (95% CI) | Heterogeneity I2 (%) |
|---|---|---|---|---|
| All-cause mortality | 36/1,998 | 4 | 1.4 (0.4–3.1) | 84 |
| Cardiac-related mortality | 20/1,498 | 3 | 1.1 (0.2–2.7) | 79 |
| PPM | 122/1,998 | 4 | 6.0 (4.0–8.4) | 77 |
| CVA | 52/1,998 | 4 | 2.7 (1.7–3.8) | 55 |
| Thromboembolism | 19/1,998 | 4 | 0.5 (0–1.9) | 88 |
| Bleeding | 32/1,267 | 3 | 2.4 (0.03–7.6) | 95 |
| Severe PVL | 13/1,498 | 3 | 0.7 (0.1–1.6) | 59 |
| Valve thrombosis | 0/1,998 | 4 | – | – |
| Endocarditis | 2/1,998 | 4 | – | – |
| Explantation | 22/1,998 | 4 | 1.1 (0.6–1.6) | 0 |
| SVD | 0/1,518 | 3 | – | – |
N, number of studies; CI, confidence interval; PPM, permanent pacemaker; CVA, cerebrovascular accident (stroke and TIA included); PVL, paravalvular leakage; SVD, structural valve deterioration/degeneration.